Eagle Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Eagle Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-91,915	Closed	-$4.61M	–	688
2015 Q1	$4.61M	Sell	91,915 -2,883	-3%	-$121K	0.03%	442
2014 Q4	$3.29M	Buy	94,798 +29,066	+44%	+$1.01M	0.02%	483
2014 Q3	$2.15M	Sell	65,732 -4,728	-7%	-$167K	0.01%	569
2014 Q2	$2.7M	Sell	70,460 -30,827	-30%	-$1.08M	0.01%	560
2014 Q1	$4.03M	Buy	+101,287	New	+$4.53M	0.02%	508

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Eagle Asset Management's KYTH Position: Q2 2015 in Review

Eagle Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 91,915 shares — an estimated $4.61M sold.

Eagle Asset Management first reported a position in KYTH in Q1 2014 and held it in 5 quarters. The position peaked at $4.61M in Q1 2015. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

Eagle Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
Eagle Asset Management sold 91,915 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $4.61M.
Eagle Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 5 quarters.
Eagle Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $4.61M in Q1 2015.
153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Eagle Asset Management's 13F filing for Q2 2015, filed 15 Jul 2015.